Phase II study of irinotecan in patients with chemotherapy pretreated angiosarcoma.
Phase 2
- Conditions
- angiosarcoma
- Registration Number
- JPRN-UMIN000008187
- Lead Sponsor
- ational Cancer Center Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 18
Inclusion Criteria
Not provided
Exclusion Criteria
a) pregnancy b) severe infection c) interstitual peumonia or lungfibrosis d) symptomatic CNS metastasis e) HIV infection
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method